Old Web
English
Sign In
Acemap
>
authorDetail
>
Donald E. Wilder
Donald E. Wilder
Pfizer
Biochemistry
Glycogen phosphorylase
In vivo
Internal medicine
Endocrinology
3
Papers
84
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor.
2004
American Journal of Physiology-heart and Circulatory Physiology
W. Ross Tracey
Judith L. Treadway
William P. Magee
Jill C. Sutt
R. Kirk McPherson
Carolyn B. Levy
Donald E. Wilder
Li J. Yu
Yue Chen
Ravi Mysore Shanker
Alison K. Mutchler
Andrew H. Smith
David M. Flynn
Delvin R. Knight
Show All
Source
Cite
Save
Citations (48)
Hemodynamic effects of the renin inhibitor CP-80,794 in several species
1990
William R. Murphy
Ronald Thure Wester
Robert Louis Rosati
Dennis J. Hoover
Irene M. Purcell
Joseph T. MacAndrew
Teresa M. Schelhorn
Donald E. Wilder
Andrew H. Smith
William F. Holt
Show All
Source
Cite
Save
Citations (10)
1